Abstract:Macrophage migration inhibitory factor (MIF), an immunoregulatory protein, is a potential target for a number of inflammatory diseases. In the current work, the interactions between MIF and a series of phenolic hydrazones were studied by molecular docking, molecular dynamics (MD) simulations, binding free energy calculations, and binding energy decomposition analysis to determine the structural requirement for achieving favorable biological activity of phenolic hydrazones. First, molecular docking was used to predict the binding modes of inhibitors in the binding site of MIF. The good correlation between the predicted docking scores and the experimental activities shows that the binding conformations of the inhibitors in the active site of MIF are well predicted. Moreover, our results suggest that the flexibility of MIF is essential in ligand binding process. Then, MD simulations and MM/GBSA free energy calculations were employed to determine the dynamic binding process and compare the binding modes of the inhibitors with different activities. The predicted binding free energies given by MM/GBSA are not well correlated with the experimental activities for the two subsets of the inhibitors; however, for each subset, a good correlation between the predicted binding free energies and the experimental activities is achieved. The MM/GBSA free energy decomposition analysis highlights the importance of hydrophobic residues for the MIF binding of the studied inhibitors. Based on the essential factors for MIF-inhibitor interactions derived from the theoretical predictions, some derivatives were designed and the higher inhibitory activities of several candidates were confirmed by molecular docking studies. The structural insights obtained from our study are useful for designing potent inhibitors of MIF.

Current developments of macrophage migration inhibitory factor (MIF) inhibitors.

[The Functions and Clinical Studies of Macrophage Migration Inhibitory Factor].

Discovery of Novel Inhibitors Targeting the Macrophage Migration Inhibitory Factor Via Structure-Based Virtual Screening and Bioassays.

Macrophage Migration Inhibitory Factor (MIF) in CNS Diseases: Functional Regulation and Potential Therapeutic Indication

Critical Role of Macrophage Migration Inhibitory Factor in Autoimmune and Inflammatory Diseases

[Research progress in macrophage migration inhibitory factor (MIF) in tumor immune response]

Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis

Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus

Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer

The roles of macrophage migration inhibitory factor in retinal diseases

[Functional Roles of Macrophage Migration Inhibitory Factor in Anti-Parasitic Diseases].

Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

The immunobiology of MIF: function, genetics and prospects for precision medicine

Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders

Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays

A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects Against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice.

Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations.

Identification and Structure-Activity Relationships of Dietary Flavonoids As Human Macrophage Migration Inhibitory Factor (MIF) Inhibitors.

Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders

An integrated signal transduction network of macrophage migration inhibitory factor